Severe cardiac toxicity in hematological stem cell transplantation: Predictive value of reduced left ventricular ejection fraction

Bone Marrow Transplantation

Volumn 27, Issue 3, 2001, Pages 307-310

  Fujimaki, K ^a   Maruta, A ^a   Yoshida, M ^a   Sakai, R ^a   Tanabe, J ^a   Koharazawa, H ^a   Kodama, F ^a   Asahina, S ^a   Minamizawa, M ^a   Matsuzaki, M ^b   Fujisawa, S ^b   Kanamori, H ^b   Ishigatsubo, Y ^b  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Anthracycline; BMT; Cardiac toxicity; Cyclophospamide; Ejection fraction

Indexed keywords

ACLARUBICIN; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN; HYDROXYUREA; IDARUBICIN; INTERFERON; MITOXANTRONE; PIRARUBICIN; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PREDICTION; PRIORITY JOURNAL; RECIPIENT; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE, CONGESTIVE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; THIOTEPA; WHOLE-BODY IRRADIATION;

EID: 17744376759     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702783     Document Type: Article

References (14)

1. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity
2. Cardiotoxicity associated with high-dose combination chemotherapy
3. Clinical spectrum of anthracycline antibiotic cardiotoxicity
4. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: Risk for cardiac toxicity
5. Cardiac toxicity of bone marrow transplantation: Predictive value of cardiologic evaluation before transplant
6. Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor
7. Risk factors for doxorubicin-induced congestive heart failure
8. Daunomycin-induced cardiotoxicity in children and adults: A review of 110 cases
9. Cardiac events in patients receiving mitoxantrone
10. Early assessment of a new drug analogue: Are the historical comparisons obsolete? The French experience with pirarubicin
11. Idarubicin cardiotoxicity: A retrospective study in acute myeloid leukemia and myelodysplasia
12. Antitumor activity of new anthracycline antibiotics, Aclacinomycin-A and its analogs and their toxicity
13. Doxorubicin-induced cardiomyopathy
14. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation